SC
NEO icon

Scotia Capital’s NeoGenomics NEO Stock Holding History

Scotia Capital’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,111
Closed -$149K – 899
2024
Q3 		$149K Buy
+10,111
New +$158K ﹤0.01% 793

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Scotia Capital's NEO Position: Q4 2024 in Review

Scotia Capital sold out of NeoGenomics (NEO) in Q4 2024, closing a stake of 10,111 shares — an estimated $149K sold.

Scotia Capital first reported a position in NEO in Q3 2024 and held it in 1 quarter. The position peaked at $149K in Q3 2024. 253 funds tracked by Wall St. Rank hold NEO as of Q4 2024.

  • Scotia Capital reported no remaining NeoGenomics position as of Q4 2024 after selling out during the quarter.
  • Scotia Capital sold 10,111 NeoGenomics shares in Q4 2024, an estimated $149K.
  • Scotia Capital first reported a position in NeoGenomics in Q3 2024 and held it in 1 quarter.
  • Scotia Capital's NeoGenomics position peaked at $149K in Q3 2024.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2024.

Based on Scotia Capital's 13F filing for Q4 2024, filed 13 Feb 2025.